SKI Market

A+| A| A-|

Indian Indices

Sensex

78,127.36 -389.13
( -0.50%)

Global Indices

Nasdaq

49,509.71 339.32
(0.69%)

Dow Jones

7,158.76 73.75
(1.04%)

Hang Seng

59,542.04 192.87
(0.32%)

Nikkei 225

10,480.54 -17.55
(-0.17%)

Forex

USD-INR

93.44 0.45
(0.48%)

EUR-INR

109.88 0.43
(0.39%)

GBP-INR

126.24 0.55
(0.44%)

JPY-INR

0.59 0.00
(0.27%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5510998

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

21.89

101577.75

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.66

Back

GPT Infraprojects consolidated net profit declines 5.93% in the December 2025 quarter

Jan 29,2026

Net profit of GPT Infraprojects declined 5.93% to Rs 20.15 crore in the quarter ended December 2025 as against Rs 21.42 crore during the previous quarter ended December 2024. Sales rose 2.10% to Rs 283.93 crore in the quarter ended December 2025 as against Rs 278.08 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	283.93	278.08	2
OPM %	13.51	12.18	-
PBDT	32.61	31.01	5
PBT	26.84	26.52	1
NP	20.15	21.42	-6

78,127.36 -389.13 ( -0.50%)

49,509.71 339.32 (0.69%)

7,158.76 73.75 (1.04%)

59,542.04 192.87 (0.32%)

10,480.54 -17.55 (-0.17%)

93.44 0.45 (0.48%)

109.88 0.43 (0.39%)

126.24 0.55 (0.44%)

0.59 0.00 (0.27%)